Movement Alert｜Smoore International Intraday Decline 3.12% in Regular Trading, Profit-Taking Continues After FDA-Driven Rally Exceeding 20%

Market Focus05-20

On May 20, Smoore International fell 3.12% in regular trading, trading at HK$9.96 per share, with trading volume of HK$71.26 million.

The decline represents a continued technical pullback following a sustained rally earlier this month. The US FDA's first-ever approval of non-tobacco flavored e-cigarettes through PMTA review had previously driven Smoore International's stock price up over 20% within the month, with multiple sessions of gains exceeding 5%. Since May 14, the stock has pulled back on consecutive trading days as profit-taking pressure mounted.

Institutional analysts maintain a constructive medium-to-long-term view on the company, noting that FDA regulatory direction is focused on cracking down on illegal products while easing restrictions on compliant flavored products. Smoore International, as a global core atomization equipment supplier, has developed underage identification technology considered a key factor in FDA approval decisions. Core client products and proprietary brands are expected to accelerate through the approval process, directly benefiting from the recovery of the compliant market.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1127512457?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-20 15:50","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1127512457","market":"hk","top_or_hot":-1,"title":"Movement Alert｜Smoore International Intraday Decline 3.12% in Regular Trading, Profit-Taking Continues After FDA-Driven Rally Exceeding 20%","media":"Market Focus","content":"<p><p>On May 20, Smoore International fell 3.12% in regular trading, trading at HK$9.96 per share, with trading volume of HK$71.26 million.</p><p>The decline represents a continued technical pullback following a sustained rally earlier this month. The US FDA's first-ever approval of non-tobacco flavored e-cigarettes through PMTA review had previously driven Smoore International's stock price up over 20% within the month, with multiple sessions of gains exceeding 5%. Since May 14, the stock has pulled back on consecutive trading days as profit-taking pressure mounted.</p><p>Institutional analysts maintain a constructive medium-to-long-term view on the company, noting that FDA regulatory direction is focused on cracking down on illegal products while easing restrictions on compliant flavored products. Smoore International, as a global core atomization equipment supplier, has developed underage identification technology considered a key factor in FDA approval decisions. Core client products and proprietary brands are expected to accelerate through the approval process, directly benefiting from the recovery of the compliant market.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Smoore International Intraday Decline 3.12% in Regular Trading, Profit-Taking Continues After FDA-Driven Rally Exceeding 20%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Smoore International Intraday Decline 3.12% in Regular Trading, Profit-Taking Continues After FDA-Driven Rally Exceeding 20%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-05-20 15:50</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On May 20, Smoore International fell 3.12% in regular trading, trading at HK$9.96 per share, with trading volume of HK$71.26 million.</p><p>The decline represents a continued technical pullback following a sustained rally earlier this month. The US FDA's first-ever approval of non-tobacco flavored e-cigarettes through PMTA review had previously driven Smoore International's stock price up over 20% within the month, with multiple sessions of gains exceeding 5%. Since May 14, the stock has pulled back on consecutive trading days as profit-taking pressure mounted.</p><p>Institutional analysts maintain a constructive medium-to-long-term view on the company, noting that FDA regulatory direction is focused on cracking down on illegal products while easing restrictions on compliant flavored products. Smoore International, as a global core atomization equipment supplier, has developed underage identification technology considered a key factor in FDA approval decisions. Core client products and proprietary brands are expected to accelerate through the approval process, directly benefiting from the recovery of the compliant market.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06969","symbol_name":"思摩尔国际","start_time":0,"source_url":"","article_id":"1127512457","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1127512457","pubTimestamp":1779263433,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On May 20, Smoore International fell 3.12% in regular trading, trading at HK$9.96 per share, with trading volume of HK$71.26 million.The decline represents a continued technical pullback following a...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06969":"思摩尔国际"},"translate_title":"动向提示|思摩尔国际常规交易盘中跌3.12%FDA带动涨势超20%后获利了结持续","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06969":1},"content_text":"On May 20, Smoore International fell 3.12% in regular trading, trading at HK$9.96 per share, with trading volume of HK$71.26 million.The decline represents a continued technical pullback following a sustained rally earlier this month. The US FDA's first-ever approval of non-tobacco flavored e-cigarettes through PMTA review had previously driven Smoore International's stock price up over 20% within the month, with multiple sessions of gains exceeding 5%. Since May 14, the stock has pulled back on consecutive trading days as profit-taking pressure mounted.Institutional analysts maintain a constructive medium-to-long-term view on the company, noting that FDA regulatory direction is focused on cracking down on illegal products while easing restrictions on compliant flavored products. Smoore International, as a global core atomization equipment supplier, has developed underage identification technology considered a key factor in FDA approval decisions. Core client products and proprietary brands are expected to accelerate through the approval process, directly benefiting from the recovery of the compliant market.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1127512457","isCrawlerRequest":true}